FREEDOM FROM INFLAMMATORY BOWEL DISEASE
The World’s Best Treatment Program
Inflammatory bowel disease (IBD) is a term for two conditions (Crohn’s disease and ulcerative colitis) that are characterized by chronic inflammation of the gastrointestinal (GI) tract. Prolonged inflammation results in damage to the GI tract.

Inflammatory Bowel Disease (IBD) affects more than 2.3 million people in the United States with Crohn’s disease and Ulcerative Colitis being the two main forms of the condition.

While IBD can develop at any age, it most commonly occurs in young adulthood, typically between the ages of 15 and 30. However, it can also occur in children and older adults.

Individuals with IBD are at an increased risk of developing various complications, including bowel obstructions, strictures, fistulas, abscesses, colorectal cancer, and extraintestinal manifestations affecting other organs such as the joints, skin, eyes, and liver. These complications can significantly impact quality of life and may require surgical intervention or specialized medical management.
Inflammatory Bowel Disease (IBD) can profoundly affect an individual’s quality of life, presenting with symptoms such as abdominal pain, diarrhea, fatigue, weight loss, and impaired social functioning. Beyond the physical symptoms, many individuals with IBD also grapple with psychological distress, including anxiety and depression, which can exacerbate their overall well-being and quality of life.
What is Inflammatory Bowel Disease (IBD)?
Inflammatory Bowel Disease (IBD) is a group of chronic inflammatory conditions that affect the gastrointestinal tract. The two main types of IBD are Crohn’s disease and Ulcerative Colitis. While both conditions involve inflammation of the digestive tract, they differ in terms of the location and nature of the inflammation.
Crohn’s disease can affect any part of the gastrointestinal tract, from the mouth to the anus. It is characterized by inflammation that extends through the entire thickness of the intestinal wall and can involve skip lesions, meaning that healthy areas of tissue may be interspersed between areas of inflammation. Common symptoms of Crohn’s disease include abdominal pain, diarrhea, fatigue, weight loss, and reduced appetite. Complications may include strictures, fistulas, abscesses, and malnutrition.
Ulcerative Colitis primarily affects the colon (large intestine) and rectum. It is characterized by inflammation and ulcers that typically start in the rectum and may extend continuously along the colon. Symptoms of Ulcerative Colitis include abdominal pain, bloody diarrhea, urgency to have bowel movements, and tenesmus (the feeling of needing to pass stools even when the rectum is empty). Complications may include severe bleeding, perforation of the colon, and an increased risk of colon cancer.
The exact cause of IBD is not fully understood, but it is believed to involve a combination of genetic, environmental, and immunological factors. Genetics play a significant role, as individuals with a family history of IBD are at a higher risk of developing the condition. Environmental factors such as diet, smoking, and exposure to certain infections may also contribute to the development of IBD. Additionally, abnormalities in the immune system, including dysregulation of immune responses and inflammation, play a central role in the pathogenesis of IBD.
Inflammatory Bowel Disease (IBD) Symptoms
Do you suspect or know that you have Inflammatory Bowel Disease (IBD)? You may experience symptoms such as these:
- Persistent Diarrhea.
- Abdominal Pain and Cramping.
- Fatigue.
- Weight Loss.
- Rectal Bleeding.
- Fever.
- Abdominal Swelling and Bloating.
- Nausea and Vomiting.
- Reduced Appetite.
- Joint Pain.
- Skin Problems.
- Eye Problems
- Mouth Ulcers

Traditional Treatments for Inflammatory Bowel Disease (IBD)
Traditional treatments for Inflammatory Bowel Disease (IBD) aim to control inflammation, alleviate symptoms, achieve and maintain remission, and prevent complications. Treatment plans are individualized based on the type and severity of IBD, as well as the patient’s response to therapy. Here are some common traditional treatments for IBD:
Anti-Inflammatory Medications: Anti-inflammatory drugs are often used as first-line therapy to reduce inflammation in the gastrointestinal tract and alleviate symptoms. Aminosalicylates, such as mesalamine and sulfasalazine, are commonly prescribed for mild to moderate cases of Ulcerative Colitis. Corticosteroids, such as prednisone and budesonide, may be used for short-term treatment of moderate to severe flares of Crohn’s disease or Ulcerative Colitis.
Immunomodulators: Immunomodulatory medications work by suppressing the immune system to reduce inflammation and prevent disease progression in IBD. Thiopurines, such as azathioprine and 6-mercaptopurine, and methotrexate are examples of immunomodulators commonly used in the treatment of IBD, particularly for maintaining remission and reducing the need for corticosteroids.
Biologic Therapies: Biologic therapies target specific molecules involved in the inflammatory process, such as tumor necrosis factor-alpha (TNF-alpha) or integrins, to block inflammation and promote healing of the intestinal lining. Biologics, including anti-TNF agents (e.g., infliximab, adalimumab, and certolizumab) and anti-integrin agents (e.g., vedolizumab and natalizumab), are used to treat moderate to severe cases of Crohn’s disease and Ulcerative Colitis, particularly when other treatments have been ineffective or poorly tolerated.
Antibiotics: Antibiotics may be prescribed to treat bacterial overgrowth or infections in the gastrointestinal tract, which can exacerbate symptoms and contribute to inflammation in IBD. Antibiotics such as metronidazole and ciprofloxacin may be used as adjunctive therapy in certain cases of Crohn’s disease or Ulcerative Colitis.
Symptom Management: In addition to anti-inflammatory medications and immunosuppressants, symptomatic treatments may be prescribed to alleviate specific symptoms associated with IBD. These may include anti-diarrheal agents, pain relievers, antispasmodics, and dietary supplements to address nutritional deficiencies.
Surgical Intervention: In cases of severe or refractory IBD, surgical intervention may be necessary to remove diseased portions of the intestine, repair complications such as strictures or fistulas, or improve quality of life. Surgical options for IBD include bowel resection, ileostomy or colostomy, and colectomy with ileal pouch-anal anastomosis (IPAA).
Finding the Root Cause
Inflammatory Bowel Disease (IBD) is a multifactorial condition with complex origins, necessitating comprehensive exploration to identify underlying factors contributing to its onset. While the precise etiology of IBD remains elusive, several potential contributors have been implicated in its development.
- Genetic Predisposition: There is compelling evidence suggesting a genetic component to IBD, with specific genetic variations increasing susceptibility to the condition. Individuals with a family history of IBD are at a higher risk of developing the condition themselves. Variants in genes associated with the immune system, such as those involved in regulating inflammatory responses and gut barrier function, may play a key role in disease pathogenesis.
- Dysregulated Immune Response: Dysfunction of the immune system is believed to be a central factor in the development of IBD. Abnormalities in immune function, including aberrant responses to gut microbiota, chronic inflammation, and impaired tolerance to intestinal antigens, contribute to the initiation and perpetuation of intestinal inflammation characteristic of IBD. Dysregulation of immune cells, cytokines, and inflammatory mediators further exacerbates tissue damage and disease progression.
- Environmental Triggers: Environmental factors may play a significant role in triggering or exacerbating IBD in genetically susceptible individuals. Factors such as diet, exposure to microbial pathogens, alterations in the gut microbiome, antibiotic use, smoking, and stress have been implicated as potential triggers for disease onset or flares. Environmental factors may interact with genetic predisposition to modulate immune responses, alter gut barrier function, and influence the composition of the gut microbiota, contributing to the pathogenesis of IBD.
- Lifestyle Factors: Lifestyle choices, including diet, physical activity, stress management, and smoking, can influence the risk of developing IBD and may impact disease severity and progression. Adherence to a Western diet high in processed foods, refined sugars, and saturated fats has been associated with an increased risk of IBD, while consumption of a diet rich in fruits, vegetables, whole grains, and omega-3 fatty acids may have protective effects. Additionally, physical inactivity, chronic stress, and smoking have been linked to an increased risk of developing IBD and worsening disease outcomes.
Hundreds experience freedom from Inflammatory Bowel Disease with Dr. Walter Campbell
98%
love their experience
Joy Callaghan
CROHN’S DISEASE
My symptoms that have improved are: Every single one!!!!
Brian Hamilton
ULCERATIVE COLITIS
By the second month I had no more symptoms
Larry Jones
CHRON’S DISEASE
The healing process in going very,very well. This is real good stuff
Amy Keck
ULCERATIVE COLITIS
I woke up with no symptoms of anything.
Start Your Health Consultation
We’ve set up a comprehensive new patient special that includes everything necessary to determine the root cause of your condition and start you on the journey to getting your life back.
Optimal wellness is just a click away.